Provide Guidance on Oral Etrasimod for Ulcerative Colitis
August 2024
Etrasimod (Velsipity) will be an oral once-daily option for moderate to severe ulcerative colitis (UC) in adults.
It’s the second sphingosine 1-phosphate (S1P) receptor modulator approved for ulcerative colitis...after po once-daily ozanimod (Zeposia).
S1P receptor modulators are thought to reduce inflammation by preventing white blood cells from moving from lymph nodes into the colon.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive